
Ellipsys AV fistula system set for 2026 market return
The ultrasound-guided system is expected to return to commercial availability in mid-2026 for percutaneous AV fistula creation in hemodialysis patients.
Section
Every story we've published, newest first. 318 articles.

The ultrasound-guided system is expected to return to commercial availability in mid-2026 for percutaneous AV fistula creation in hemodialysis patients.

The deal adds View Point’s FDA-cleared OneMark tissue-localization system to Merit’s oncology portfolio and complements the company’s SCOUT breast-localization platform.

Integrity Medical Service will sell, implement, and support the multisource digital tomosynthesis system across Colorado, Wyoming, and parts of Kansas and Nebraska.

The deal adds a teleradiology group that provides about 350,000 annual reads for outpatient imaging centers and orthopedic practices.

The Phase 1 first-in-human trial is evaluating RYZ401, an Ac-225-labeled radiopharmaceutical targeting somatostatin receptors in neuroendocrine tumors and other solid tumors.

Stumpe will join Siemens Healthineers on June 1 after serving as chief technology and AI officer at Danaher.

The recall covers Azurion interventional fluoroscopy systems after Philips identified cases where X-ray imaging may not start or may occur intermittently when using the wired foot switch.

The warning letter cites complaint handling, corrective action, and manufacturing-control issues tied to NAMIC angiographic control syringes used with radiographic contrast media.